// App-Quantinova.ai

P1208 : CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REPORT FROM THE PROSPECTIVE INTERNATIONAL T-CELL LYMPHOMA PROJECT

Researchers

Presenter

  • Carlos Chiattone

Principal Investigators

  • Thais Fischer

  • Eliana Miranda

  • Martina Manni

  • Natalia P C Zing

  • Stefano A Pileri

  • Silvia Montoto

  • Steven M Horwitz

  • Maria Elena Cabrera

  • Carmino A De Souza

  • Arnon Nagler

  • Stefano Luminari

  • Andrs J M Ferreri

  • Kenneth R Carson

  • Alessandro Re

  • Luigi Rigacci

  • Luca Nassi

  • Massimo Federico

  • Giorgio Inghirami

Medical Centers

  • S.O.D. Ematologia Dipartimento Area Critica Medico Chirurgica,A.O.U. Careggi,Firenze,Italien

  • Hematology and Hemotherapy Center,University of Campinas,Sau Paulo,Brésil

  • W Pathology and Laboratory Medicine,New York Presbyterian Hospital, We

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Hematology Division, BMT and Cord Blood Bank, Chaim Sheba Medical Center, Tel-Hashomer, Israel

  • Hematology and Hemotherapy Center,University of Campinas,Sau Paulo,Brésil

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Oncology Saint Louis, Internal Medicine,Washington University School of Medicine,Washington,États-unis

  • Department of Translational Medicine,AOU Maggiore della Carità

  • Sección Hematología,Hospital del Salvador, Universidad de Chile,Santiago de Chile,Chile

  • Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan, Italy

  • W Pathology and Laboratory Medicine,New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York.eill Cornell Medical College ,New York,États-unis

  • Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil

  • Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • CHIMOMO ,University of Modena and Reggio Emilia,Modena,Italien

  • Department of Haemato-Oncology,St Bartholomew's Hospital, Barts Health NHS Trust,London,Royaume-uni

  • S.O.D. Ematologia Dipartimento Area Critica Medico Chirurgica,A.O.U. Careggi,Firenze,Italien

  • Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan, Italy

  • S.O.D. Ematologia Dipartimento Area Critica Medico Chirurgica,A.O.U. Careggi,Firenze,Italien

  • CHIMOMO ,University of Modena and Reggio Emilia,Modena,Italien

  • W Pathology and Laboratory Medicine,New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York.eill Cornell Medical College ,New York,États-unis

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Division of Diagnostic Haematopathol

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan, Italy

  • Sección Hematología,Hospital del Salvador, Univer

  • Department Medicine,Memorial Sloan-Kettering Cancer Center,New York,Vereinigte Staaten

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

  • CHIMOMO ,University of Moden

  • UO Ematologia A.O,Spedali Civili di Brescia,Brescia,Italie

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

  • Hematology Division, BMT and Cord Blood Bank, Chaim Sheba Medical Center, Tel-Hashomer, Israel

  • UO Ematologia A.O,Spedali Civili di Brescia,Brescia,Italie

  • S.O.D. Ematologia Dipartimento Area Critica Medico Chirurgica,A.O.U. Careggi,Firenze,Italien

  • UO Ematologia A.O,Spedali Civili di Brescia,Brescia,Italie

  • S.O.D. Ematologia Dipartimento A

  • Department of Translational Medicine,AOU Maggiore della Carità and University of Eastern Piedmont,Novara,Italien

  • UO Ematologia A.O,Spedali Civili di Brescia,Br

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Sección Hematología,Hospital del Salvador, Universidad de Chile,Santiago de Chile,Chile

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

  • CHIMOMO ,University of Modena and Reggio Emilia,Modena,Italien

  • Leukemia Service, Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,États-unis

  • Medicine,Mem Sloan Kettering Cancer Center,New York,United States

  • Sección Hematología,Hospital del Salvador, Universidad de Chile,Santiago de Chile,Chile

  • Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy

  • CHIMOMO ,University of Moden

  • Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy

  • Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Department of Haemato-Oncology,St Bartholomew's Hospital, Barts Health NHS Trust,London,Royaume-uni

  • Hematology and Hemotherapy Center,University of Campinas,Sau Paulo,Brésil

  • Santa Casa Medi

  • CHIMOMO ,University of Modena and Reggio Emilia,Modena,Italien

  • Oncology Saint Louis, Internal Medicine,Washington University School of Medicine,Washington,États-unis

  • Division of Diagnostic Haematopathology, European Institute of Oncology, IRCCS, Milan, Italy

  • Oncology Saint Louis, Internal Medicine,Washington University School of Medicine,Washington,États-unis

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Department of Translational Medicine,AOU Maggiore della Carità and University of Eastern Piedmont,Novara,Italien

  • Department of Translational Medicine,AOU Maggiore della Carità and University of Eastern Piedmont,Novara,Italien

  • Oncology Saint Louis, Internal Medicine,Washington University School of Medicine,Washington,États-unis

  • Hematology Division, BMT and Cord Blood Bank, Chaim Sheba Medical Center, Tel-Hashomer, Israel

  • Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy

  • UO Ematologia A.O,Spedali Civili di Brescia,Brescia,Italie

  • CHIMOMO ,University of Modena and Reggio Emilia,Modena,Italien

  • Lymp

  • Department of Haemato-Oncology,St Bartholomew's Hospital, Barts Health NHS Trust,London,Royaume-uni

  • Department of Haemato-Oncology,St Bartholomew's Hospital, Barts Health NHS Trust,London,Royaume-uni

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • UO Ematologia A.O,Spedali Civili di Brescia,Brescia,Italie

  • Santa Casa Medical School,Sao Paulo and Samaritano Hospital,Sau Paulo,Brasilien

  • Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil

  • Hematology Division, BMT and Cord Blood Bank, Chaim Sheba Medical Center, Tel-Hashomer, Israel

  • Hematology and Hemotherapy Cen

Locations

  • Italy

  • Brazil

  • United Kingdom

  • United States

  • Chile

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell lymphoma

  • Peripheral T-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved